• OPEN AN ACCOUNT
Indian Indices
Sensex
81,028.02 1,718.01
( 2.17%)
Global Indices
Nasdaq
51,462.04 -82.02
(-0.16%)
Dow Jones
7,424.83 50.10
(0.68%)
Hang Seng
57,293.47 -3,784.43
(-6.20%)
Nikkei 225
10,662.59 -120.07
(-1.11%)
Forex
USD-INR
94.41 -0.18
(-0.19%)
EUR-INR
106.07 -0.23
(-0.22%)
GBP-INR
127.18 -0.23
(-0.18%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
39.1
943.25
EPS(TTM)
Face Value()
Div & Yield %
20.47
10
0.06
 

Jaihind Industries reports standalone nil net profit/loss in the March 2026 quarter
May 29,2026
Jaihind Industries reported no net profit/loss in the quarter ended March 2026 as against net loss of Rs 0.03 crore during the previous quarter ended March 2025. Sales rose 150.00% to Rs 0.05 crore in the quarter ended March 2026 as against Rs 0.02 crore during the previous quarter ended March 2025.

For the full year,net profit remain constant at Rs 0.02 crore in the year ended March 2026 and also during the previous year ended March 2025. Sales rose 42.86% to Rs 0.20 crore in the year ended March 2026 as against Rs 0.14 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.050.02 150 0.200.14 43
OPM %20.00-100.00 -15.0021.43 -
PBDT0.01-0.02 LP 0.030.03 0
PBT0.01-0.02 LP 0.030.03 0
NP0-0.03 100 0.020.02 0